Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Feb 7, 2017 · 10-Q · 38 days after period end · 0001615774-17-000400
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$3.15M | -$3.95M | -$786.72K | $358.64K |
| EPS Diluted | -$0.08 | -$0.12 | -$0.06 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Feb 7, 2017 · 38 d after period end
